Bioactivity of biosilica obtained from North Atlantic deep-sea sponges
Demosponges are a well-known source of a plethora of bioactive compounds. In particular, they are able to form a skeleton by direct deposition of silica in a process catalysed by silicatein. Herein, we isolated biosilicas from five different Atlantic deep-sea sponges Geodia atlantica (GA), Geodia ba...
| Published in: | Frontiers in Marine Science |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article in Journal/Newspaper |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1822/72768 https://doi.org/10.3389/fmars.2021.637810 |
| Summary: | Demosponges are a well-known source of a plethora of bioactive compounds. In particular, they are able to form a skeleton by direct deposition of silica in a process catalysed by silicatein. Herein, we isolated biosilicas from five different Atlantic deep-sea sponges Geodia atlantica (GA), Geodia barretti (GB), Stelletta normani (SN), Axinella infundibuliformis (AI) and Phakellia ventilabrum (PV) to explore the bioactivity and osteogenic capacity of its silica-based materials. We chemically characterized the isolated biosilicas and evaluated them for their bioactivity to deposit Ca and P on their surface (by immersion in simulated body fluid, SBF). GB-, SN-, AI- and PV-based biosilicas did not generate a stable calcium phosphate (CaP) layer over time in the presence of SBF, however, the GA-derived one was able to form a CaP surface layer (at a Ca/P ratio of ~1.7, similar to the one observed for hydroxyapatite), that was stable during the 28 days of testing. In addition, no cytotoxicity towards L929 and SaOs2 cells was observed for the GA-based biosilica up to a concentration of 10 mg/mL. Overall, the GA-based biosilica presents the characteristics to be used in the development of biomaterials for bone tissue engineering (BTE). This research has been performed with funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreements No. 679849 (SponGES) and No. 668983 (FORECAST). Funding from the European Regional Development Fund, through Atlantic Area Program, under the scope of BlueHuman project (EAPA_151/2016) is also acknowledged. JRX research was also supported by National Funds through FCT, the Portuguese Foundation for Science and Technology within the scope of UIDB/04423/2020, UIDP/04423/2020, and ... |
|---|